Search Results

Pharmacogenetics and pharmacogenomics of sexual dysfunction: current status, gaps and potential applications

Authors: Abdel-Hamid, Ibrahim A; Andersson, Karl-Erik

Source: Pharmacogenomics, Volume 10, Number 10, October 2009 , pp. 1625-1644(20)

Publisher: Future Medicine

Improved Erectile Function after Cardiac Resynchronization Therapy in a Patient with Heart Failure—A Case Report

Authors: Domanski, Damian; Rosanio, Salvatore; Schwarz, Ernst R.

Source: The Journal of Sexual Medicine, Volume 6, Number 10, October 2009 , pp. 2910-2914(5)

Publisher: Blackwell Publishing

Editorial [Hot topic: Phosphodiesterase-5 Inhibitors and their Use in the Treatment of Urological Conditions (Executive Editor: Perimenis Petros)]

Author: Petros, Perimenis

Source: Current Pharmaceutical Design, Volume 15, Number 30, October 2009 , pp. 3463-3463(1)

Publisher: Bentham Science Publishers

Prophylaxis of Erectile Function After Radical Prostatectomy with Phosphodiesterase Type 5 Inhibitors

Authors: Deho, F.; Gallina, A.; Salonia, A.; Briganti, A.; Suardi, N.; Zanni, G.; Guazzoni, G.; Rigatti, P.; Montorsi, F.

Source: Current Pharmaceutical Design, Volume 15, Number 30, October 2009 , pp. 3496-3501(6)

Publisher: Bentham Science Publishers

Phosphodiesterase-5 Inhibitors: Future Perspectives

Authors: Konstantinos, Giannitsas; Petros, Perimenis

Source: Current Pharmaceutical Design, Volume 15, Number 30, October 2009 , pp. 3540-3551(12)

Publisher: Bentham Science Publishers

Emerging Treatments in Cystic Fibrosis

Authors: Jones, Andrew M.; Helm, Jennifer M.

Source: Drugs, Volume 69, Number 14, 1 October 2009 , pp. 1903-1910(8)

Publisher: Adis International

Effect of vardenafil on endothelial progenitor cells in hypogonadotrophic hypogonadal patients: role of testosterone treatment

Authors: Foresta, Carlo; Di Mambro, Antonella; Caretta, Nicola; De Toni, Luca; Zuccarello, Daniela; Ferlin, Alberto

Source: Clinical Endocrinology, Volume 71, Number 3, September 2009 , pp. 412-416(5)

Publisher: Blackwell Publishing

Is there a rationale for the chronic use of phosphodiesterase-5 inhibitors for lower urinary tract symptoms secondary to benign prostatic hyperplasia?

Authors: Roumeguère, Thierry; Zouaoui Boudjeltia, K.; Hauzeur, Claude; Schulman, Claude; Vanhaeverbeek, Michel; Wespes, Eric

Source: BJU International, Volume 104, Number 4, August 2009 , pp. 511-517(7)

Publisher: Blackwell Publishing

Pulmonary Hypertension in Patients with Chronic Obstructive Pulmonary Disease: Advances in Pathophysiology and Management

Authors: >Joan Albert Barberà,; Blanco, Isabel

Source: Drugs, Volume 69, Number 9, 18 June 2009 , pp. 1153-1171(19)

Publisher: Adis International

Have phosphodiesterase-5 inhibitors changed the indications for penile implants?

Authors: Cortés-González, Jeff R.; Glina, Sidney

Source: BJU International, Volume 103, Number 11, June 2009 , pp. 1518-1521(4)

Publisher: Blackwell Publishing

Substrate-specific pharmacokinetic interaction between endothelin receptor antagonists and phosphodiesterase-5 inhibitors - assembling the clues

Author: Srinivas, Nuggehally R.

Source: British Journal of Clinical Pharmacology, Volume 67, Number 4, April 2009 , pp. 475-477(3)

Publisher: Blackwell Publishing

Salvage robotic-assisted radical prostatectomy: initial results and early report of outcomes

Authors: Boris, Ronald S.; Bhandari, Akshay; Krane, L. Spencer; Eun, Daniel; Kaul, Sanjeev; Peabody, James O.

Source: BJU International, Volume 103, Number 7, April 2009 , pp. 952-956(5)

Publisher: Blackwell Publishing

Phosphodiesterase-5 inhibitors and rosacea: report of 10 cases

Authors: Ioannides, D.; Lazaridou, E.; Apalla, Z.; Devliotou-Panagiotidou, D.

Source: British Journal of Dermatology, Volume 160, Number 3, March 2009 , pp. 719-720(2)

Publisher: Blackwell Publishing

Recent Advances in the Management of Pulmonary Arterial Hypertension

Authors: Papadakis, Emmanuel; Michalopoulos, Argyris

Source: Current Respiratory Medicine Reviews, Volume 5, Number 1, February 2009 , pp. 41-48(8)

Publisher: Bentham Science Publishers

Phosphodiesterase-5 inhibitors for the treatment of Raynaud's: a novel indication

Authors: De LaVega, Alfonso J; Derk, Chris T

Source: Expert Opinion on Investigational Drugs, Volume 18, Number 1, January 2009 , pp. 23-29(7)

Publisher: Informa Healthcare

Treatment of Pulmonary Hypertension in Children with Chronic Lung Disease with Newer Oral Therapies

Authors: Krishnan, Usha; Krishnan, Sankaran; Gewitz, Michael

Source: Pediatric Cardiology, Volume 29, Number 6, November 2008 , pp. 1082-1086(5)

Publisher: Springer

Alfuzosin attenuates erectile dysfunction in rats with partial bladder outlet obstruction

Authors: Gur, Serap; Sikka, Suresh C.; Chandra, Surabhi; Koka, Padma Sandeep; Agrawal, Krishna C.; Kadowitz, Philip J.; Hellstrom, Wayne J.G.

Source: BJU International, Volume 102, Number 11, December 2008 , pp. 1651-1657(7)

Publisher: Blackwell Publishing

Combination therapy with prostacyclin and tadalafil for severe pulmonary arterial hypertension: A pilot study

Authors: BENDAYAN, Daniele; SHITRIT, David; KRAMER, MordechaiR.

Source: Respirology, Volume 13, Number 6, September 2008 , pp. 916-918(3)

Publisher: Blackwell Publishing

The pharmacological treatment of premature ejaculation

Authors: Giuliano, François; Hellstrom, Wayne J.G.

Source: BJU International, Volume 102, Number 6, September 2008 , pp. 668-675(8)

Publisher: Blackwell Publishing

Survey of Treatment Practices for Sexual Dysfunction(s) Associated with Anti-Depressants

Authors: Balon, Richard; Segraves, R. Taylor

Source: Journal of Sex and Marital Therapy, Volume 34, Number 4, July 2008 , pp. 353-365(13)

Publisher: Routledge, part of the Taylor & Francis Group